232 related articles for article (PubMed ID: 9026985)
1. [A comparison of the morphofunctional characteristics of the peripheral blood lymphocytes and the immune status of patients with malignant melanoma of the skin].
Naleskina LA; Ganina KP; Labunets IF; Grinevich IuA; Abramenko VA
Tsitol Genet; 1996; 30(5):16-22. PubMed ID: 9026985
[TBL] [Abstract][Full Text] [Related]
2. [Hormonal function of the thymus in malignant melanoma of the skin; the interrelation with immune system disorders].
Grinevich IuA; Labunets IF
Vopr Onkol; 1987; 33(6):46-52. PubMed ID: 3617600
[TBL] [Abstract][Full Text] [Related]
3. Thymosin-inducible lymphocytes in the peripheral blood of patients with malignant melanoma.
Byrom NA; Campbell MA; Dean AJ; Timlin DM; Volkers C; Bodenham DC; Hobbs JR
Cancer Treat Rep; 1978 Nov; 62(11):1769-74. PubMed ID: 310343
[TBL] [Abstract][Full Text] [Related]
4. [Immunologic reaction-readiness in malignant melanoma].
Bickhardt R; Kunze J
Z Hautkr; 1974 Apr; 49(8):315-33. PubMed ID: 4599330
[No Abstract] [Full Text] [Related]
5. [Changes in certain immunological parameters in patients with malignant skin melanoma].
Lukács L; Bárdosi L; Somos Z; Kocsis B
Orv Hetil; 1985 Apr; 126(14):819-26. PubMed ID: 3873050
[No Abstract] [Full Text] [Related]
6. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
Serov AA; Kadagidze ZG
Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
[TBL] [Abstract][Full Text] [Related]
7. [Immune status of patients with malignant melanoma during combined therapy including local ultra-high frequency hyperthermia].
Risina DIa; Zhakov IG; Fradkin SZ; Zhabrid EA
Vopr Onkol; 1989; 35(12):1437-40. PubMed ID: 2532801
[TBL] [Abstract][Full Text] [Related]
8. Increased number of cytotoxic CD3+ CD28- gammadelta T cells in peripheral blood of patients with cutaneous malignant melanoma.
Campillo JA; Martínez-Escribano JA; Minguela A; López-Alvarez R; Marín LA; García-Alonso AM; Bensussan A; Alvarez-López MR
Dermatology; 2007; 214(4):283-8. PubMed ID: 17460398
[TBL] [Abstract][Full Text] [Related]
9. [Immune profile in melanoma patients. I. PHA--stimulation of circulating lymphocytes and number of T- and B-lymphocytes (author's transl)].
Knopf B; Wätzig V; Knöll B
Arch Geschwulstforsch; 1978; 48(6):559-64. PubMed ID: 310289
[TBL] [Abstract][Full Text] [Related]
10. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
[TBL] [Abstract][Full Text] [Related]
11. The in vitro effect of a calf thymus extract on the peripheral blood lymphocytes of sixty-six melanoma patients.
Bernengo MG; Capella G; de Matteis A; Tovo PA; Zina G
Clin Exp Immunol; 1979 May; 36(2):279-84. PubMed ID: 314368
[TBL] [Abstract][Full Text] [Related]
12. Biologic and immunomodulatory events after CTLA-4 blockade with ticilimumab in patients with advanced malignant melanoma.
Reuben JM; Lee BN; Li C; Gomez-Navarro J; Bozon VA; Parker CA; Hernandez IM; Gutierrez C; Lopez-Berestein G; Camacho LH
Cancer; 2006 Jun; 106(11):2437-44. PubMed ID: 16615096
[TBL] [Abstract][Full Text] [Related]
13. Autochthonous primary and metastatic melanomas in Hgf-Cdk4 R24C mice evade T-cell-mediated immune surveillance.
Landsberg J; Gaffal E; Cron M; Kohlmeyer J; Renn M; Tüting T
Pigment Cell Melanoma Res; 2010 Oct; 23(5):649-60. PubMed ID: 20649939
[TBL] [Abstract][Full Text] [Related]
14. Detection of specific immunoreactivity by LAI assay in patients with malignant melanoma of uveal tissue.
Kalafut F; Cernák A; Pham Manh Hung
Neoplasma; 1979; 26(3):299-305. PubMed ID: 394010
[TBL] [Abstract][Full Text] [Related]
15. Mutual relationship between total and active T lymphocytes in patients with malignant tumors.
Babusíková O; Babusík P; Novotná L
Neoplasma; 1978; 25(1):67-74. PubMed ID: 305544
[TBL] [Abstract][Full Text] [Related]
16. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
[TBL] [Abstract][Full Text] [Related]
17. Direct identification of T cells in malignant melanoma of the choroid.
Puliafito CA; Wilkes BM; Albert DM
Int Ophthalmol Clin; 1980; 20(2):93-102. PubMed ID: 6995394
[No Abstract] [Full Text] [Related]
18. The skin immune system and the challenge of tumour immunosurveillance.
Woods GM; Malley RC; Muller HK
Eur J Dermatol; 2005; 15(2):63-9. PubMed ID: 15757812
[TBL] [Abstract][Full Text] [Related]
19. [Disordered differentiation of the immunocompetent cells in sarcoidosis and sarcoids of the skin].
Samtsov AV; Korol'kova TN
Vestn Dermatol Venerol; 1990; (1):13-5. PubMed ID: 2327164
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and immunologic characteristics of patients with histiocytosis X].
Goncharova SI; Poddubnyĭ AF; Panasiukova OR
Probl Tuberk; 1993; (2):30-2. PubMed ID: 7984564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
